Ocular Inflammation

Ocular inflammation is a common side effect after eye surgery, and it can lead to complications including macular cystoid edoema. Pharmacologic therapy and less invasive surgical procedures are frequently used to treat it. Ocular inflammation has become a hot topic in ophthalmology, encompassing internal medicine, surgery, fundamental research, physiology, pharmacology, microbiology, immunology, rheumatology, pharmacology, and laboratory medicine. The orbit, ocular adnexa, ocular surface, conjunctiva, cornea, sclera, uvea, retinal vessels, and optic nerve are all affected by ocular inflammatory disorders. The origin and prognosis of ocular inflammation range from benign, self-limited illnesses to organ-threatening disorders, posing diagnostic and therapeutic problems.

•    Grand Challenges
•    Causes and Symptoms
•    Risk Factors
•    Diagnosis 
•    Treatment

Market Analysis:
The global Ocular Inflammation Treatment market size is projected to reach USD 21460 million by 2026, from USD 20230 million in 2020, at a CAGR of 5.5%% during 2021-2026.